Atlantic Coast Rehab & Health Medicare and Medicaid Location: 485 River Ave, Lakewood, New Jersey 08701 Ratings: Phone: (732) 364-7100 |
Leisure Chateau Rehabilitation Medicare and Medicaid Location: 962 River Ave, Lakewood, New Jersey 08701 Ratings: Phone: (732) 370-8600 |
Leisure Park Health Center Medicare and Medicaid Location: 1400 Route 70, Lakewood, New Jersey 08701 Ratings: Phone: (732) 370-0444 |
Harrogate Medicare Location: 400 Locust Street, Lakewood, New Jersey 08701 Ratings: Phone: (732) 905-7070 |
Concord Healthcare & Rehabilitation Center Medicare and Medicaid Location: 963 Ocean Ave, Lakewood, New Jersey 08701 Ratings: Phone: (732) 367-7444 |
Fountain View Care Center Medicare and Medicaid Location: 527 River Avenue, Lakewood, New Jersey 08701 Ratings: Phone: (732) 905-0700 |
News Archive
Patients with severe asthma who use an internet-supported strategy and daily monitoring of exhaled nitric oxide were able to control their asthma with lower overall dosing of oral corticosteroids than patients who underwent usual care, according to research from the Netherlands.
A newly developed spectroscopy method is helping to clarify the poorly understood molecular process by which an anti-HIV drug induces lethal mutations in the virus's genetic material.
Ruthigen, Inc., announced today enrollment of the first patient in a Randomized, Double-Blind Phase 1/2 clinical trial to evaluate the safety, tolerability, and potential efficacy of its lead drug candidate, RUT58-60, for use as an adjunct to systemic antibiotics in abdominal surgery.
Today is World TB Day. Although there is much to celebrate, with 49 million lives being saved through the diagnosis and treatment of tuberculosis (TB) between 2000 and 2015, the rise in TB-causing bacteria that are resistant to key treatments now threatens to derail decades of progress in controlling TB.
Reverse Medical Corporation today announced FDA clearance for US commercialization of their MVP-5 Micro Vascular Plug system for peripheral vessel embolization, and the first US clinical case. The MVP-5 system is indicated for use to obstruct or reduce the rate of blood flow in the peripheral vasculature, in vessels measuring between 3.0 and 5.0 mm.
› Verified 3 days ago